Renalytix plc - ADS (RNLXY)

CUSIP: 75973T101

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / ADS
Total 13F shares
3,290,829
Share change
+34,828
Total reported value
$7,961,875
Put/Call ratio
55%
Price per share
$2.42
Number of holders
18
Value change
+$161,636
Number of buys
10
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 75973T101?
CUSIP 75973T101 identifies RNLXY - Renalytix plc - ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Renalytix plc - ADS (RNLXY) as of Q1 2023

As of 31 Mar 2023, Renalytix plc - ADS (RNLXY) was held by 18 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,290,829 shares. The largest 10 holders included GILDER GAGNON HOWE & CO LLC, PINNACLE ASSOCIATES LTD, Pentwater Capital Management LP, Tejara Capital Ltd, CI Private Wealth, LLC, LAZARD ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, MORGAN STANLEY, North Star Investment Management Corp., and CITADEL ADVISORS LLC. This page lists 18 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.